Baker Bros. Raises Stake in Vanda Pharma (VNDA) to 13.99%
Tweet
Share
E-mailGet Alerts VNDA Hot Sheet
Join SI Premium – FREE
In a 13G filing on Vanda Pharmaceuticals, Inc. (NASDAQ: VNDA), hedge fund Baker Bros. Advisors, LLC disclosed a 13.99%, or 3,966,179 share, stake in the company.
This is up 104.72% from the 1,937,390 shares held at the end of the latest quarter ending March 31, 2013.
For more notable holders of Vanda Pharmaceuticals, Inc. stock click here.
This is up 104.72% from the 1,937,390 shares held at the end of the latest quarter ending March 31, 2013.
For more notable holders of Vanda Pharmaceuticals, Inc. stock click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- EU grants Vanda's imsidolimab first orphan status for rare skin disease
- Vanda Pharmaceuticals Granted Orphan Designation for Imsidolimab for the Treatment of Generalized Pustular Psoriasis by the European Commission
- Walmart expected to beat Q2 estimates as tariff refunds lift margins
Create E-mail Alert Related Categories
13Gs, Hedge FundsRelated Entities
Hedge Funds, 13GSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
